Skip to main content

Criteria for AAEBI Standards

Clipboard image

Program developers may submit programs for evaluation by a panel of expert reviewers. To be considered eligible for evaluation, applicants will be required to meet the stated eligibility criteria and submit the following documentation to demonstrate eligibility:

  • Complete peer-reviewed journal article(s) describing the program, arthritis population evaluated, and significance of arthritis outcomes impacted via program participation
  • Program implementation guidance – any infrastructure documents developed to assist delivery partners in implementing your program locally, whether virtually or in person (e.g., training manuals, fidelity assessments for delivery partners, other program delivery guidance as relevant)

The 2022 Application Cycle is now closed. Please check back in 2023 for the next round of evaluation.

If you have submitted a program in the 2022 Application Cycle, notification of your program’s AAEBI status will occur by September 15, 2022.

AAEBI Evaluation Overview

Downloadable Seal of AAEBI recognition
Downloadable Seal of AAEBI recognition

The purpose of the Arthritis-Appropriate, Evidence-Based Intervention (AAEBI) Evaluation Process is to review the Centers for Disease Control and Prevention’s published process for program evaluation, update the process as needed, and employ the process to screen promising intervention programs for elevation to recognized interventions that are proven to improve the quality of life of people with arthritis. Learn more about the AAEBI program review process and criteria here.

Programs were evaluated by a national group of reviewers with extensive expertise in arthritis research, AAEBIs, program evaluation, and program implementation. This activity was supported by the Centers for Disease Control and Prevention of the U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $865,211 with 100 percent funded by CDC/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement by, CDC/HHS, or the U.S. Government.